Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of INCB099280 in Advanced Solid Tumors
jRCT2031220663Phase 1Completed
- Sponsor
- Incyte
- Start
- Apr 2023
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of incb099280 in Nonhematologic neoplasms (3 cohorts), sponsored by Incyte. Primary endpoint: Number of treatment-emergent adverse events. Started Apr 2023; status: completed.
02
Drugs
incb099280
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2031220663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220663.